Job title: Head of Complement Cluster
Michael J. Storek has over a decade of the Complement System experience. He served as a Laboratory Head of Taligen Therapeutics, and after Taligen Therapeutics was acquired by Alexion, he continued to work as a Laboratory Head of Alexion Pharmaceuticals in Cambridge. He consulted for many leading VC companies regarding the Companies in the Complement System space and since November 2019, he is the Head of the Complement program at Sanofi.
Chair’s Closing Remarks & End of Day One 5:45 pm
day: Day One